NCT04405999View on ClinicalTrials.gov

Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

August 9, 2020

Study Completion Date

August 31, 2020

Conditions
Increased Risk of SARS-CoV-2 Infection
Interventions
DRUG

Bromhexine Hydrochloride

Medical personnel at risk for COVID-19 infection will receive study medication for 14 days

Trial Locations (1)

197341

Almazov National Medical Research Centre, Saint Petersburg

All Listed Sponsors
lead

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

OTHER

NCT04405999 - Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease | Biotech Hunter | Biotech Hunter